Rafferty Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.95M | Sell |
79,146
-21,661
| -21% | -$2.72M | 0.03% | 270 |
|
|
2025
Q1 | $11.1M | Sell |
100,807
-6,204
| -6% | -$686K | 0.05% | 243 |
|
|
2024
Q4 | $14.6M | Sell |
107,011
-33,824
| -24% | -$4.62M | 0.05% | 216 |
|
|
2024
Q3 | $16.2M | Buy |
140,835
+17,837
| +15% | +$2.06M | 0.06% | 182 |
|
|
2024
Q2 | $16.9M | Buy |
122,998
+57,128
| +87% | +$7.86M | 0.06% | 173 |
|
|
2024
Q1 | $9.08M | Sell |
65,870
-10,679
| -14% | -$1.47M | 0.03% | 296 |
|
|
2023
Q4 | $10.1M | Sell |
76,549
-4,941
| -6% | -$651K | 0.04% | 277 |
|
|
2023
Q3 | $9.17M | Sell |
81,490
-7,541
| -8% | -$848K | 0.05% | 246 |
|
|
2023
Q2 | $8.4M | Buy |
89,031
+18,043
| +25% | +$1.7M | 0.05% | 251 |
|
|
2023
Q1 | $7.19M | Buy |
70,988
+2,334
| +3% | +$236K | 0.05% | 287 |
|
|
2022
Q4 | $8.2M | Buy |
68,654
+3,525
| +5% | +$421K | 0.07% | 252 |
|
|
2022
Q3 | $6.92M | Buy |
65,129
+24,727
| +61% | +$2.63M | 0.07% | 228 |
|
|
2022
Q2 | $3.94M | Sell |
40,402
-19,494
| -33% | -$1.9M | 0.04% | 334 |
|
|
2022
Q1 | $5.62M | Sell |
59,896
-6,304
| -10% | -$591K | 0.03% | 358 |
|
|
2021
Q4 | $5.64M | Buy |
66,200
+33,986
| +106% | +$2.89M | 0.03% | 341 |
|
|
2021
Q3 | $3.09M | Buy |
32,214
+5,764
| +22% | +$553K | 0.02% | 460 |
|
|
2021
Q2 | $2.57M | Sell |
26,450
-7,886
| -23% | -$767K | 0.02% | 585 |
|
|
2021
Q1 | $3.34M | Buy |
34,336
+24,002
| +232% | +$2.33M | 0.02% | 420 |
|
|
2020
Q4 | $991K | Sell |
10,334
-9,432
| -48% | -$905K | 0.01% | 497 |
|
|
2020
Q3 | $1.9M | Buy |
19,766
+8,621
| +77% | +$829K | 0.02% | 431 |
|
|
2020
Q2 | $1.36M | Buy |
11,145
+6,864
| +160% | +$838K | 0.02% | 460 |
|
|
2020
Q1 | $371K | Sell |
4,281
-31,334
| -88% | -$2.72M | 0.02% | 384 |
|
|
2019
Q4 | $3.83M | Sell |
35,615
-31,629
| -47% | -$3.4M | 0.06% | 176 |
|
|
2019
Q3 | $6.06M | Buy |
67,244
+8,325
| +14% | +$750K | 0.09% | 125 |
|
|
2019
Q2 | $4.98M | Sell |
58,919
-5,611
| -9% | -$474K | 0.09% | 165 |
|
|
2019
Q1 | $5.69M | Buy |
+64,530
| New | +$5.69M | 0.09% | 117 |
|